In May 2025, the FDA approved numerous biosimilars as interchangeable with Stelara® (ustekinumab) and Humira® (adalimumab), bringing the total ...

The Centers for Medicare and Medicaid Services (CMS) has pulled Biden-era guidance telling hospital emergency departments to ...

As cancer drug deaths pile up, doctors are increasingly testing for gene variants that can cause thousands of patients to ...

Mineralys Therapeutics, Inc.'s lorundrostat shows promise for treating aldosterone-driven hypertension with FDA approval by ...

Despite Health Secretary Robert F Kennedy Jr’s announcement ending covid-19 vaccine recommendations for healthy children and ...

WASHINGTON - Nearly two-thirds of U.S. health care practitioners who say a majority of their patients smoke mistakenly ...

Ho (V/R), June 3, GNA – The Food and Drugs Authority (FDA), in collaboration with key stakeholders, has launched the 2025 ...

The FDA rolled out a generative AI tool for speeding regulatory reviews, announcing its launch nearly a month ahead of a June ...

By Godfred Aaneamenga Polkuu Bolgatanga, June 02, GNA – The Upper East Regional Office of the Food and Drugs Authority (FDA), ...

Vaccination rates across the country have continued to fall since the height of the pandemic, but the coronavirus never ...

A new report reveals toxic metals such as arsenic and cadmium were found in rice sold in the U.S., posing health risks such ...

The trial will evaluate AXPAXLI in at least 555 patients in a multi-center, double-masked, randomized (2:2:1), 3-arm study.